Similarly, empagliflozin suppresses NLRP3 inflammasome activation in macrophages of diabetic patients (Kim et al., 2020)
10 Safety of Liraglutide: Pancreatitis has rarely been experienced by patients taking liraglutide (7 cases in phase II and III trials of 4,257 patients), prompting the close monitoring of the development of pancreatitis in patients prescribed liraglutide
Diabetes Care , 42(12), 2566-2575
LiFLeierALiuQWangYXiangDAkutsuTet al
Regular screening may be done if you have risk factors or symptoms such as fatigue, numbness, or pale skin
Sasaki R, Nishmura N, Hoshino H, Isa Y, Kadowaki M, Ichi T, et al